Back to Journals » International Journal of Nephrology and Renovascular Disease » Volume 9

The cost-utility of treating anemia with continuous erythropoietin receptor activator or Epoetin versus routine blood transfusions among chronic hemodialysis patients

Total article views   HTML views PDF downloads Totals
12,552 Dovepress* 10,535+ 2,144 12,679
PubMed Central* 2,017 428 2,445
Totals 12,552 2,572 15,124
*Since 24 February 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar